,,yes,,, its more probable that up to 50% of the net worth of 208 will go to the partner or partners on this next leg. The failure of BoM will have somewhat crippled DMcCs' ability to push a deal more in our favor possibly. The partner/s are in the drivers seat imo unless Hepa and or KD step in to finish off BoM2. Its not impossible to stretch that idea. Plus our blood bank,,plus those other 1200 molecules,,,plus that 10 year lead over everyone else in this field! The longer we go here the weaker our shares get on one side of the equation but the other side would indicate they will get stronger with confirmation...no matter what happens,,,,the existing major investors will steer us in the most favorable direction which coincides with their interests! I dont anticipate being shafted by our major insiders although nothing in these markets are impossible to think of,,,jmo.